Huang-ju Tu
250 Wuxing Street
Taipei, TNQ 11031, Taiwan
Taipei, TNQ 11031, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Artificial intelligence-driven drug discovery: a new era in therapeutic innovation.
Journal: Bioorganic & medicinal chemistry
Published: January 31, 2026
Discovery of a novel RSK2 inhibitor for the treatment of metastatic pancreatic cancer.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: August 05, 2025
Identification and Biological Evaluation of a Novel CLK4 Inhibitor Targeting Alternative Splicing in Pancreatic Cancer Using Structure-Based Virtual Screening.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 05, 2024
Discovering a novel dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) inhibitor and its impact on tau phosphorylation and amyloid-β formation.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: November 04, 2024
Discovery of dual-specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) inhibitors using an artificial intelligence model and their effects on tau and tubulin dynamics.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 15, 2024
Identification, biological evaluation, and crystallographic analysis of coumestrol as a novel dual-specificity tyrosine-phosphorylation-regulated kinase 1A inhibitor.
Journal: International journal of biological macromolecules
Published: March 21, 2024
In silico identification of a novel Cdc2-like kinase 2 (CLK2) inhibitor in triple negative breast cancer.
Journal: Protein science : a publication of the Protein Society
Published: January 02, 2024
Identification of selective dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors and their effects on tau and microtubule.
Journal: International journal of biological macromolecules
Published: April 28, 2023
In silico identification and biological evaluation of a selective MAP4K4 inhibitor against pancreatic cancer.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: January 23, 2023
Urolithin A exhibits a neuroprotective effect against Alzheimer's disease by inhibiting DYRK1A activity.
Journal: Journal of food and drug analysis
Published: January 06, 2023
O-methylated flavonol as a multi-kinase inhibitor of leukemogenic kinases exhibits a potential treatment for acute myeloid leukemia.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: September 28, 2021
Identification and analysis of a selective DYRK1A inhibitor.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: September 09, 2021
Last Updated: 09/26/2026